Related Experiment Video
Updated: Aug 18, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol
Nigel Toussaint1, Kim Mullins, Jonathon Snider
1Department of Nephrology, St Vincent's Hospital, Melbourne, Victoria, Australia. Nigel.Toussaint@mh.org.au
Background:
Peritonitis has a significant impact upon morbidity and mortality of peritoneal dialysis (PD) patients. Gram-positive organisms account for the majority of infections and vancomycin is a cost effective broad-spectrum antimicrobial treatment for PD peritonitis, but this may lead to the emergence of multiple antibiotic-resistant organisms. The purpose of the present paper was to evaluate the efficacy of a non-vancomycin-based protocol comprising cephazolin and gentamicin, which was introduced in the present PD population as empirical treatment for peritonitis.
Methods:
The study involved 82 peritonitis episodes over a 4-year period in 58 patients, excluding those with previous methicillin-resistant staphylococcal peritonitis.
Results:
With cephazolin and gentamicin there was no apparent difference in response or relapse rates in comparison to reported studies using vancomycin-based first-line therapy protocols.
Conclusion:
We advocate initial treatment of PD peritonitis with non-vancomycin-based therapy given similar efficacy and the potential for reduction of resistant organisms.
Insights
A new study suggests that using cephazolin and gentamicin for peritoneal dialysis (PD) peritonitis is as effective as vancomycin. This non-vancomycin approach may help reduce antibiotic resistance in PD patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Pharmacology
Background:
- Peritonitis significantly impacts morbidity and mortality in peritoneal dialysis (PD) patients.
- Gram-positive organisms are the most common cause of PD peritonitis.
- Vancomycin is a common treatment but can lead to antibiotic resistance.
Purpose of the Study:
- To evaluate the efficacy of a non-vancomycin empirical treatment protocol for PD peritonitis.
- The protocol utilized cephazolin and gentamicin.
Main Methods:
- The study analyzed 82 peritonitis episodes over 4 years in 58 PD patients.
- Patients with prior methicillin-resistant staphylococcal peritonitis were excluded.
Main Results:
- The cephazolin and gentamicin protocol showed no difference in response or relapse rates compared to vancomycin-based protocols.
- This suggests comparable efficacy to traditional vancomycin therapy.
Conclusions:
- Initial treatment of PD peritonitis with non-vancomycin therapy (cephazolin and gentamicin) is advocated.
- This approach offers similar efficacy and potential for reducing antibiotic resistance.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Acute Pyelonephritis II: Diagnostic Studies and Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Acute Kidney Injury V: Interprofessional Care
Antimicrobial Effectiveness